Found 7 matching trials
An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies
PHASE1This open-label, extension study is designed to provide continuing treatmen...
Location
Sarcoma Oncology Center
A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.
PHASE1This study will determine the maximum tolerated dose of RO5045337 and the o...
Location
Multiple Locations
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
PHASE1This multi-center, open-label, Phase 1b study will evaluate the safety, pha...
Location
Multiple Locations
A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma
PHASE1This multicenter, open-label, Phase 1b study will evaluate the safety, phar...
Location
Multiple Locations
A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors
PHASE1This study will determine the maximum tolerated dose and the optimal associ...
Location
Multiple Locations
A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery
PHASE1This open-label study will evaluate efficacy, safety and tolerability of RO...
Location
Multiple Locations
A Study of RO5045337 in Patients With Solid Tumors
PHASE1This open-label, randomized, cross-over study will evaluate the effect of f...
Location
Multiple Locations